Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03793465 · ClinicalTrials.gov registry record · Phase 1
Pilot-Tart Cherry, Mitral Transcriptome, and POAF Incidence
A Phase 1 study of Post-operative Atrial Fibrillation (POAF), sponsored by University of Michigan.
- Active
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03793465: Active Phase 1 study of Post-operative Atrial Fibrillation (POAF), sponsored by University of Michigan.
NCT03793465 is a Phase 1 study of Post-operative Atrial Fibrillation (POAF) that is active but no longer recruiting, run by University of Michigan. The registered enrollment target is 50 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (17% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03793465, a Phase 1 study of Post-operative Atrial Fibrillation (POAF), is active but no longer recruiting, sponsored by University of Michigan.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Assess impact of Tart Cherry Concentrate in cardiac surgical patients on POAF and related clinical and economic outcomes. Measure inflammation gene transcripts in cardiac tissue.
Primary Outcome
Patients will complete a brief questionnaire regarding gastrointestinal status, using the Bristol Stool Form Scale
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT tart cherry concentrate
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-02-08 |
| Est. Completion | 2027-01 |
| Phase | Phase 1 |
What the registry record for NCT03793465 still lists
NCT03793465 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (17% lower).
The record links to 1 condition, with Post-operative Atrial Fibrillation (POAF) appearing as the primary indexed condition, and to 1 intervention - of which tart cherry concentrate is the first listed.
NCT03793465 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03793465 about?
NCT03793465 is a clinical study titled "Pilot-Tart Cherry, Mitral Transcriptome, and POAF Incidence". Assess impact of Tart Cherry Concentrate in cardiac surgical patients on POAF and related clinical and economic outcomes. Measure inflammation gene transcripts in cardiac tissue.
What is the current status of trial NCT03793465?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2019-02-08. Estimated completion is 2027-01.
What conditions does trial NCT03793465 study?
This clinical trial studies the following conditions: Post-operative Atrial Fibrillation (POAF).
What interventions are being tested in trial NCT03793465?
The interventions under investigation include: tart cherry concentrate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03793465?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03793465 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post-operative Atrial Fibrillation (POAF)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03793465's enrollment target sits among peer trials
50 973rd of 2000 higher than 984 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI